119 related articles for article (PubMed ID: 12711842)
1. The risk of radiation-induced carcinogenesis after external beam radiotherapy of Graves' orbitopathy.
Akmansu M; Dirican B; Bora H; Gurel O
Ophthalmic Res; 2003; 35(3):150-3. PubMed ID: 12711842
[TBL] [Abstract][Full Text] [Related]
2. Risk of developing radiogenic cancer following photon-beam radiotherapy for Graves' orbitopathy.
Mazonakis M; Tzedakis A; Lyraraki E; Damilakis J
Med Phys; 2018 Oct; 45(10):4775-4782. PubMed ID: 30105825
[TBL] [Abstract][Full Text] [Related]
3. [Radiation dose in critical organs due to non-coplanar irradiation of the hypophysis].
Schulte RW; Rittmann KL; Meinass HJ; Rennicke P
Strahlenther Onkol; 1996 Sep; 172(9):501-6. PubMed ID: 8928057
[TBL] [Abstract][Full Text] [Related]
4. Probable risk of tumour induction after retro-orbital irradiation for Graves' ophthalmopathy.
Snijders-Keilholz A; De Keizer RJ; Goslings BM; Van Dam EW; Jansen JT; Broerse JJ
Radiother Oncol; 1996 Jan; 38(1):69-71. PubMed ID: 8850428
[TBL] [Abstract][Full Text] [Related]
5. Evaluation of radiation carcinogenesis risk in vertebral hemangioma treated by radiotherapy.
Beyzadeoglu M; Dirican B; Oysul K; Surenkok S; Pak Y
Neoplasma; 2002; 49(5):338-41. PubMed ID: 12458334
[TBL] [Abstract][Full Text] [Related]
6. Assessment of a carcinogenic risk for treatment of Graves' ophthalmopathy in dependence on age and irradiation geometry.
Broerse JJ; Snijders-Keilholz A; Jansen JT; Zoetelief J; Klein C; Seegenschmiedt MH
Radiother Oncol; 1999 Dec; 53(3):205-8. PubMed ID: 10660199
[TBL] [Abstract][Full Text] [Related]
7. Radiotherapy for Graves' orbitopathy: randomised placebo-controlled study.
Mourits MP; van Kempen-Harteveld ML; García MB; Koppeschaar HP; Tick L; Terwee CB
Lancet; 2000 Apr; 355(9214):1505-9. PubMed ID: 10801172
[TBL] [Abstract][Full Text] [Related]
8. Doses to radiation sensitive organs and structures located outside the radiotherapeutic target volume for four treatment situations.
Foo ML; McCullough EC; Foote RL; Pisansky TM; Shaw EG
Int J Radiat Oncol Biol Phys; 1993 Sep; 27(2):403-17. PubMed ID: 8407417
[TBL] [Abstract][Full Text] [Related]
9. [Radiotherapy for Graves' ophthalmopathy].
Kuhnt T; Müller AC; Janich M; Gerlach R; Hädecke J; Duncker GI; Dunst J
Klin Monbl Augenheilkd; 2004 Nov; 221(11):915-21. PubMed ID: 15562354
[TBL] [Abstract][Full Text] [Related]
10. A retrospective study on the efficacy of total absorbed orbital doses of 12, 16 and 20 Gy combined with systemic steroid treatment in patients with Graves' orbitopathy.
Johnson KT; Wittig A; Loesch C; Esser J; Sauerwein W; Eckstein AK
Graefes Arch Clin Exp Ophthalmol; 2010 Jan; 248(1):103-9. PubMed ID: 19865824
[TBL] [Abstract][Full Text] [Related]
11. [Graves' orbitopathy].
Balázs C
Orv Hetil; 2006 Jun; 147(22):1011-7. PubMed ID: 16913090
[TBL] [Abstract][Full Text] [Related]
12. Heel spur radiotherapy and radiation carcinogenesis risk estimation.
Surenkok S; Dirican B; Beyzadeoglu M; Oysul K
Radiat Med; 2006 Oct; 24(8):573-6. PubMed ID: 17041794
[TBL] [Abstract][Full Text] [Related]
13. Graves' disease radioiodine-therapy: choosing target absorbed doses for therapy planning.
Willegaignon J; Sapienza MT; Coura-Filho GB; Watanabe T; Traino AC; Buchpiguel CA
Med Phys; 2014 Jan; 41(1):012503. PubMed ID: 24387527
[TBL] [Abstract][Full Text] [Related]
14. Orbital irradiation for Graves' ophthalmopathy: Is it safe? A long-term follow-up study.
Wakelkamp IM; Tan H; Saeed P; Schlingemann RO; Verbraak FD; Blank LE; Prummel MF; Wiersinga WM
Ophthalmology; 2004 Aug; 111(8):1557-62. PubMed ID: 15288988
[TBL] [Abstract][Full Text] [Related]
15. Place of radiotherapy in the treatment of Graves' orbitopathy.
Beckendorf V; Maalouf T; George JL; Bey P; Leclere J; Luporsi E
Int J Radiat Oncol Biol Phys; 1999 Mar; 43(4):805-15. PubMed ID: 10098436
[TBL] [Abstract][Full Text] [Related]
16. Risk estimation of radiation-induced thyroid cancer from treatment of brain tumors in adults and children.
Mazonakis M; Damilakis J; Varveris H; Fasoulaki M; Gourtsoyiannis N
Int J Oncol; 2003 Jan; 22(1):221-5. PubMed ID: 12469208
[TBL] [Abstract][Full Text] [Related]
17. [Treatment of Graves' ophthalmopathy with irradiation].
Slampa P; Spurný V; Seneklová Z; Krákorová D
Vnitr Lek; 1998 Aug; 44(8):461-3. PubMed ID: 10358449
[TBL] [Abstract][Full Text] [Related]
18. Orbital radiotherapy for Graves' ophthalmopathy.
Bartalena L; Marcocci C; Tanda ML; Rocchi R; Mazzi B; Barbesino G; Pinchera A
Thyroid; 2002 Mar; 12(3):245-50. PubMed ID: 11952048
[TBL] [Abstract][Full Text] [Related]
19. Supervoltage orbital radiotherapy in 36 cases of Graves' disease.
Lloyd WC; Leone CR
Am J Ophthalmol; 1992 Apr; 113(4):374-80. PubMed ID: 1558110
[TBL] [Abstract][Full Text] [Related]
20. Importance of protocol target definition on the ability to spare normal tissue: an IMRT and 3D-CRT planning comparison for intraorbital tumors.
Hein PA; Gladstone DJ; Bellerive MR; Hug EB
Int J Radiat Oncol Biol Phys; 2005 Aug; 62(5):1540-8. PubMed ID: 16029816
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
